The Hospital Injectable Drugs Market is segmented, By Type (Generic Sterile Injectables, Sterile Intravenous (IV) Solutions), Application (Cardiology & Metabolic disorders, Neurology, Oncology, Autoimmune, Gastroenterology, Hematology, Infectious Diseases, and Others), End-User (Hospital Pharmacy, Retail Pharmacy, E-commerce), and Region – (North America, Europe, Asia-Pacific, and Rest of the World).
What are hospital injectable drugs?
Hospital injectable drugs can be defined as medications which are introduced into the patient’s body with the help of injections. These drugs are injected directly into the bloodstream with the help of injectable devices such as syringes and needles.
Key Players
Key players operating in the Hospital Injectable Drugs market are-
- Baxter International Inc. (US)
- Sanofi S.A. (France)
- Pfizer Inc. (US)
- GlaxoSmithKline plc (UK)
- AstraZeneca plc (UK)
- Gilead Sciences, Inc. (US)
- Merck & Co., Inc. (US)
- Novartis International AG (Switzerland)
- Johnson & Johnson (US)
- Novo Nordisk A/S (Denmark)
Market Dynamics
The growth of the hospital injectable drugs market is primarily driven by an increasing number of people suffering from chronic diseases and accidental injuries. Expanding the geriatric populace across geographies is expected to drive market growth at a significant rate during the review period. In addition to this, increasing investment in research and development activities to develop advanced healthcare solutions is likely to create lucrative opportunities for the players operating in the global hospital injectable drugs market in the coming years.
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.
